Viewpoint: A method to estimate the cost in lives of ethics board review of biomedical research
- 15 March 2011
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 269 (4), 396-402
- https://doi.org/10.1111/j.1365-2796.2011.02351_2.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Equipoise Lost: Ethics, Costs, and the Regulation of Cancer Clinical ResearchJournal of Clinical Oncology, 2010
- Controversy and Quality Improvement: Lingering Questions About Ethics, Oversight, and Patient Safety ResearchThe Joint Commission Journal on Quality and Patient Safety, 2008
- Multicentre drug trials, ethics approval and death of patientsInternal Medicine Journal, 2008
- Adverse effects of a multicentre system for ethics approval on the progress of a prospective multicentre trial of cancer treatment: how many patients die waiting?Internal Medicine Journal, 2007
- Variation in Institutional Review processes for a multisite observational studyThe American Journal of Surgery, 2005
- The Cost of Institutional Review Board Procedures in Multicenter Observational ResearchAnnals of Internal Medicine, 2003
- Controlling Research TrialsNew England Journal of Medicine, 2003
- Use of Reperfusion Therapy for Acute Myocardial Infarction in the United StatesCirculation, 1998
- Cost-benefit analysis.BMJ, 1993
- RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2The Lancet, 1988